OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 495
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 495
Showing 26-50 of 495 citing articles:
Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China
Changying Shi, Yulong Li, Cheng‐Ta Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Changying Shi, Yulong Li, Cheng‐Ta Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy
Jun Gao, Yuan Fang, Jiafeng Chen, et al.
Oncogene (2023) Vol. 42, Iss. 33, pp. 2507-2520
Closed Access | Times Cited: 21
Jun Gao, Yuan Fang, Jiafeng Chen, et al.
Oncogene (2023) Vol. 42, Iss. 33, pp. 2507-2520
Closed Access | Times Cited: 21
MYC determines lineage commitment in KRAS-driven primary liver cancer development
Luana D’Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 141-149
Open Access | Times Cited: 17
Luana D’Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 141-149
Open Access | Times Cited: 17
A real-time interpretable artificial intelligence model for the cholangioscopic diagnosis of malignant biliary stricture (with videos)
Xiang Zhang, Dehua Tang, Jindong Zhou, et al.
Gastrointestinal Endoscopy (2023) Vol. 98, Iss. 2, pp. 199-210.e10
Closed Access | Times Cited: 16
Xiang Zhang, Dehua Tang, Jindong Zhou, et al.
Gastrointestinal Endoscopy (2023) Vol. 98, Iss. 2, pp. 199-210.e10
Closed Access | Times Cited: 16
CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma
Wenwei Liao, Jinpeng Du, Lian Li, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
Wenwei Liao, Jinpeng Du, Lian Li, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
Fibroblasts in liver cancer: functions and therapeutic translation
Silvia Affò, Aveline Filliol, Gregory J. Gores, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 748-759
Open Access | Times Cited: 16
Silvia Affò, Aveline Filliol, Gregory J. Gores, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 748-759
Open Access | Times Cited: 16
Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities
Hengdong Qu, Junli Liu, Di Zhang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1930-1930
Open Access | Times Cited: 16
Hengdong Qu, Junli Liu, Di Zhang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1930-1930
Open Access | Times Cited: 16
Menghua Zhou, Hongjun Yu, Miaoyu Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 777-790
Open Access | Times Cited: 7
LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
YU Shaobo, Xin Gao, Sidi Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 552-561
Closed Access | Times Cited: 7
YU Shaobo, Xin Gao, Sidi Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 552-561
Closed Access | Times Cited: 7
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C. Benedikt Westphalen, et al.
European Journal of Cancer (2024) Vol. 203, pp. 114046-114046
Open Access | Times Cited: 7
Danmei Zhang, Klara Dorman, C. Benedikt Westphalen, et al.
European Journal of Cancer (2024) Vol. 203, pp. 114046-114046
Open Access | Times Cited: 7
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo
Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 6
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 6
Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers
Haotian Liao, Xing Chen, Haichuan Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1747-1763
Open Access | Times Cited: 6
Haotian Liao, Xing Chen, Haichuan Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1747-1763
Open Access | Times Cited: 6
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
Aviral Kumar, Bandari BharathwajChetty, Mukesh Kumar Manickasamy, et al.
Pharmacological Research (2024) Vol. 203, pp. 107167-107167
Open Access | Times Cited: 6
Aviral Kumar, Bandari BharathwajChetty, Mukesh Kumar Manickasamy, et al.
Pharmacological Research (2024) Vol. 203, pp. 107167-107167
Open Access | Times Cited: 6
Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells
Chutipa Chiawpanit, Methi Wathikthinnakorn, Nunghathai Sawasdee, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112273-112273
Open Access | Times Cited: 6
Chutipa Chiawpanit, Methi Wathikthinnakorn, Nunghathai Sawasdee, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112273-112273
Open Access | Times Cited: 6
Emerging Therapies in Management of Cholangiocarcinoma
Jessica Speckart, Veronica Rasmusen, Zohray Talib, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 613-613
Open Access | Times Cited: 5
Jessica Speckart, Veronica Rasmusen, Zohray Talib, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 613-613
Open Access | Times Cited: 5
Automatic origin prediction of liver metastases via hierarchical artificial-intelligence system trained on multiphasic CT data: a retrospective, multicentre study
Hongjie Xin, Yiwen Zhang, Qianwei Lai, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102464-102464
Open Access | Times Cited: 5
Hongjie Xin, Yiwen Zhang, Qianwei Lai, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102464-102464
Open Access | Times Cited: 5
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1018-1042
Open Access | Times Cited: 5
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1018-1042
Open Access | Times Cited: 5
SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 5
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 5
Transgenesis in parasitic helminths: a brief history and prospects for the future
Monica J. Quinzo, María Jesús Perteguer, Paul J. Brindley, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Monica J. Quinzo, María Jesús Perteguer, Paul J. Brindley, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review
Mukul Vij, Yogesh Puri, Ashwin Rammohan, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 3, pp. 607-627
Open Access | Times Cited: 24
Mukul Vij, Yogesh Puri, Ashwin Rammohan, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 3, pp. 607-627
Open Access | Times Cited: 24
Circular RNAs in cholangiocarcinoma
Wenwei Liao, Qingbo Feng, Huixian Liu, et al.
Cancer Letters (2022) Vol. 553, pp. 215980-215980
Closed Access | Times Cited: 23
Wenwei Liao, Qingbo Feng, Huixian Liu, et al.
Cancer Letters (2022) Vol. 553, pp. 215980-215980
Closed Access | Times Cited: 23
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jiafeng Chen, Xiaogang Li, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Zheng Gao, Jiafeng Chen, Xiaogang Li, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Opisthorchis viverrini—Current Understanding of the Neglected Hepatobiliary Parasite
Matthias Yi Quan Liau, En Qi Toh, Vishal G. Shelat
Pathogens (2023) Vol. 12, Iss. 6, pp. 795-795
Open Access | Times Cited: 15
Matthias Yi Quan Liau, En Qi Toh, Vishal G. Shelat
Pathogens (2023) Vol. 12, Iss. 6, pp. 795-795
Open Access | Times Cited: 15
